Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merz North America, Inc.
Age
22–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Is a candidate for bilateral IOH treatment.
Has symmetrical right and left IOHs with the same MIHAS score of 2 or 3 (moderate or severe), as assessed live by the blinded evaluator.
You may not be if
Prior lower-eyelid surgery, including orbital or midface surgery, or a permanent implant or graft in the midfacial region that could interfere with effectiveness assessments.
Previous treatment with fat injections or permanent and/or semi-permanent dermal fillers in the midfacial region.
Previous lower-eyelid and/or malar-region treatments with any dermal fillers (e.g., collagen, hyaluronic acid (HA), calcium hydroxyapatite, poly L-lactic acid (PLLA)) within the past 24 months.
Any other medical condition with the potential to interfere with the study outcome assessments or compromise subject safety.
Clareo Health | Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow
